These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 285681)

  • 1. Labetalol: bioavailability, drug plasma levels, plasma renin and catecholamines in acute and chronic treatment of resistant hypertension.
    Louis WJ; Christophidis N; Brignell M; Vijayasekaran V; McNeil J; Vajda FJ
    Aust N Z J Med; 1978 Dec; 8(6):602-9. PubMed ID: 285681
    [No Abstract]   [Full Text] [Related]  

  • 2. Labetalol in the treatment of severe essential hypertension: relationship between arterial blood pressure, plasma catecholamines, plasma renin activity, plasma aldosterone and body weight.
    Kornerup HJ; Pedersen EB; Christensen NJ; Pedersen A; Pedersen G
    Acta Med Scand Suppl; 1979; 625():59-64. PubMed ID: 34981
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of labetalol on plasma renin, aldosterone, and catecholamines in hypertensive patients.
    Lijnen PJ; Amery AK; Fagard RH; Reybrouck TM; Moerman EJ; De Schaepdryver AF
    J Cardiovasc Pharmacol; 1979; 1(6):625-32. PubMed ID: 94628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of food on the oral and intravenous pharmacokinetics of a high clearance drug: a study with labetalol.
    Daneshmend TK; Roberts CJ
    Br J Clin Pharmacol; 1982 Jul; 14(1):73-8. PubMed ID: 7104169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased first-pass metabolism of labetalol in chronic liver disease.
    Homeida M; Jackson L; Roberts CJ
    Br Med J; 1978 Oct; 2(6144):1048-50. PubMed ID: 709214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oral labetalol on plasma catecholamines, renin and aldosterone in patients with severe arterial hypertension.
    Kornerup HJ; Pedersen EB; Christensen NJ; Pedersen A; Pedersen G
    Eur J Clin Pharmacol; 1979 Nov; 16(5):305-10. PubMed ID: 520398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma catecholamines, renin and aldosterone during combined alpha- and beta- adrenoceptor blockade in patients with severe arterial hypertension.
    Kornerup HJ; Pedersen EB; Pedersen A; Pedersen G; Christensen NJ
    Postgrad Med J; 1980; 56 Suppl 2():49-52. PubMed ID: 7001422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous dilevalol. Effects of the R-R optical isomer of labetalol in patients with severe hypertension.
    Wallin JD; Cook ME; Clifton GG; Blasucci DJ; Poland M
    Arch Intern Med; 1988 Mar; 148(3):534-8. PubMed ID: 3277568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-dose pharmacokinetics of labetalol in healthy young men.
    Nyberg G; Hansson R; Tietz F
    Acta Med Scand Suppl; 1982; 665():67-73. PubMed ID: 6961762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acute and chronic hypotensive effect of labetalol and the relationship with pretreatment plasma noradrenaline levels.
    Agabiti-Rosei E; Alicandri CL; Beschi M; Castellano M; Fariello R; Montini E; Muiesan ML; Romanelli G; Muiesan G
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):87S-92S. PubMed ID: 7093104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of labetalol on the excretion of catecholamines and their metabolites in primary hypertension].
    Wocial B; Sznajderman M; Brym E; Cybulska I; Czerniewska E
    Pol Tyg Lek; 1981 Aug; 36(35):1337-9. PubMed ID: 7329848
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of labetalol in healthy volunteers.
    Kanto J; Allonen H; Kleimola T; Mäntylä R
    Int J Clin Pharmacol Ther Toxicol; 1981 Jan; 19(1):41-4. PubMed ID: 7203731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha and beta adrenergic blockade with orally administered labetalol in hypertension. Studies on blood volume, plasma renin and aldosterone and catecholamine excretion.
    Weidmann P; De Chătel R; Ziegler WH; Flammer J; Reubi F
    Am J Cardiol; 1978 Mar; 41(3):570-6. PubMed ID: 343564
    [No Abstract]   [Full Text] [Related]  

  • 14. The metabolism of labetalol in animals and man.
    Hopkins R; Martin LE; Bland R
    Biochem Soc Trans; 1976; 4(4):726-9. PubMed ID: 1001750
    [No Abstract]   [Full Text] [Related]  

  • 15. Bioavailability of labetalol increases with age.
    Kelly JG; McGarry K; O'Malley K; O'Brien ET
    Br J Clin Pharmacol; 1982 Aug; 14(2):304-5. PubMed ID: 7104187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of severe hypertension by repeated bolus injections of labetalol.
    Cumming AM; Brown JJ; Lever AF; Mackay A; Robertson JI
    Br J Clin Pharmacol; 1979; 8(Suppl 2):199S-204S. PubMed ID: 393288
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical pharmacokinetics of labetalol.
    McNeil JJ; Louis WJ
    Clin Pharmacokinet; 1984; 9(2):157-67. PubMed ID: 6370541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate of onset of hypotensive effect of oral labetalol.
    Serlin MJ; Orme MC; Maciver M; Green GJ; Macnee CM; Breckenridge AM
    Br J Clin Pharmacol; 1979 Feb; 7(2):165-8. PubMed ID: 760748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension.
    Zschiedrich H; Neurohr W; Lüth JB; Philipp T; Distler A
    Klin Wochenschr; 1983 Jul; 61(13):661-7. PubMed ID: 6310204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The response of plasma catecholamines to intravenous labetalol: a comparison with sodium nitroprusside.
    Lin MS; McNay JL; Shepherd AM; Keeton TK
    Clin Pharmacol Ther; 1983 Oct; 34(4):466-73. PubMed ID: 6617068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.